Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Murphy

Showing results (361-370 of 431) with videos related to

Pageof 44
Sort By:
Cell Metabolism|November 26, 2015
IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic SyndromeAndrew J Murphy, Michael J Kraakman, Helene L Kammoun, et al.
Cardiovascular Research|October 3, 2025
CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusionJonathan Noonan, Shania A Prijaya, Laura A Bienvenu, et al.
Pediatric Blood & Cancer|April 18, 2024
Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534Rodrigo L P Romao, Jennifer H Aldrink, Lindsay A Renfro, et al.
Nature|January 7, 2015
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsKai Deng, Mihaela Pertea, Anthony Rongvaux, et al.
Annals of Surgery|March 27, 2020
Pneumonectomy for Pediatric Tumors-a Pediatric Surgical Oncology Research Collaborative StudyStephanie F Polites, Todd E Heaton, Michael P LaQuaglia, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36Maria N Barrachina, Gerard Pernes, Isabelle C Becker, et al.
Blood|June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Neurobiology of Pain (Cambridge, Mass.)|December 15, 2023
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis painSelin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, et al.
Kidney International|December 9, 2023
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammationKarly C Sourris, Yi Ding, Scott S Maxwell, et al.
Science Immunology|January 14, 2021
Enhanced IL-36R signaling promotes barrier impairment and inflammation in skin and intestineZaruhi Hovhannisyan, Nengyin Liu, Sara Khalil-Aguero, et al.
Pageof 44

Showing results (361-370 of 431) with videos related to

Sort By:
Pageof 44
Cell Metabolism|November 26, 2015
IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic SyndromeAndrew J Murphy, Michael J Kraakman, Helene L Kammoun, et al.
Cardiovascular Research|October 3, 2025
CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusionJonathan Noonan, Shania A Prijaya, Laura A Bienvenu, et al.
Pediatric Blood & Cancer|April 18, 2024
Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534Rodrigo L P Romao, Jennifer H Aldrink, Lindsay A Renfro, et al.
Nature|January 7, 2015
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutationsKai Deng, Mihaela Pertea, Anthony Rongvaux, et al.
Annals of Surgery|March 27, 2020
Pneumonectomy for Pediatric Tumors-a Pediatric Surgical Oncology Research Collaborative StudyStephanie F Polites, Todd E Heaton, Michael P LaQuaglia, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Efficient megakaryopoiesis and platelet production require phospholipid remodeling and PUFA uptake through CD36Maria N Barrachina, Gerard Pernes, Isabelle C Becker, et al.
Blood|June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Neurobiology of Pain (Cambridge, Mass.)|December 15, 2023
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis painSelin Somersan-Karakaya, Kenneth C Turner, Luz Cortes-Burgos, et al.
Kidney International|December 9, 2023
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammationKarly C Sourris, Yi Ding, Scott S Maxwell, et al.
Science Immunology|January 14, 2021
Enhanced IL-36R signaling promotes barrier impairment and inflammation in skin and intestineZaruhi Hovhannisyan, Nengyin Liu, Sara Khalil-Aguero, et al.
Pageof 44